332 related articles for article (PubMed ID: 20205056)
1. Improving the power of diagnostics in the era of targeted therapy and personalized healthcare.
Walk EE
Curr Opin Drug Discov Devel; 2010 Mar; 13(2):226-34. PubMed ID: 20205056
[TBL] [Abstract][Full Text] [Related]
2. Personalized medicine.
Jain KK
Curr Opin Mol Ther; 2002 Dec; 4(6):548-58. PubMed ID: 12596356
[TBL] [Abstract][Full Text] [Related]
3. The current status and future potential of personalized diagnostics: Streamlining a customized process.
Richmond TD
Biotechnol Annu Rev; 2008; 14():411-22. PubMed ID: 18606372
[TBL] [Abstract][Full Text] [Related]
4. Assessing patient readiness for the clinical adoption of personalized medicine.
Issa AM; Tufail W; Hutchinson J; Tenorio J; Baliga MP
Public Health Genomics; 2009; 12(3):163-9. PubMed ID: 19204419
[TBL] [Abstract][Full Text] [Related]
5. Personalized medicine: elusive dream or imminent reality?
Lesko LJ
Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
[TBL] [Abstract][Full Text] [Related]
6. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
7. Personalized medicine: challenges in assessing and capturing value in the commercial environment.
Ferrara J
Expert Rev Mol Diagn; 2006 Mar; 6(2):129-31. PubMed ID: 16512770
[No Abstract] [Full Text] [Related]
8. [Molecular medicine--personalized medicine. Principles and state-of-the-art].
Blum HE
Dtsch Med Wochenschr; 2005 Jun; 130(25-26):1568-72. PubMed ID: 15965865
[No Abstract] [Full Text] [Related]
9. The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis.
Emerich DF; Thanos CG
Biomol Eng; 2006 Sep; 23(4):171-84. PubMed ID: 16843058
[TBL] [Abstract][Full Text] [Related]
10. Advancement in characterization of genomic alterations for improved diagnosis, treatment and prognostics in cancer.
Zhou X; Yu T; Cole SW; Wong DT
Expert Rev Mol Diagn; 2006 Jan; 6(1):39-50. PubMed ID: 16359266
[TBL] [Abstract][Full Text] [Related]
11. Next revolution in the molecular theranostics of infectious diseases: microfabricated systems for personalized medicine.
Bissonnette L; Bergeron MG
Expert Rev Mol Diagn; 2006 May; 6(3):433-50. PubMed ID: 16706745
[TBL] [Abstract][Full Text] [Related]
12. The integration of molecular diagnostics with therapeutics. Implications for drug development and pathology practice.
Ross JS; Ginsburg GS
Am J Clin Pathol; 2003 Jan; 119(1):26-36. PubMed ID: 12520694
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics in clinical practice: considerations for testing.
Constable S; Johnson MR; Pirmohamed M
Expert Rev Mol Diagn; 2006 Mar; 6(2):193-205. PubMed ID: 16512779
[TBL] [Abstract][Full Text] [Related]
14. The role of companion diagnostics in the development and use of mutation-targeted cancer therapies.
Papadopoulos N; Kinzler KW; Vogelstein B
Nat Biotechnol; 2006 Aug; 24(8):985-95. PubMed ID: 16900147
[TBL] [Abstract][Full Text] [Related]
15. New molecular assays for cancer diagnosis and targeted therapy.
Lea P; Ling M
Curr Opin Mol Ther; 2008 Jun; 10(3):251-9. PubMed ID: 18535932
[TBL] [Abstract][Full Text] [Related]
16. Integration of molecular diagnostics with therapeutics: implications for drug discovery and patient care.
Ross JS; Ginsburg GS
Expert Rev Mol Diagn; 2002 Nov; 2(6):531-41. PubMed ID: 12465450
[TBL] [Abstract][Full Text] [Related]
17. [Companion diagnostics: significances and issues in its clinical application].
Miyachi H
Rinsho Byori; 2011 Jun; 59(6):602-9. PubMed ID: 21815484
[TBL] [Abstract][Full Text] [Related]
18. Getting to personalized cancer medicine: taking out the garbage.
Compton C
Cancer; 2007 Oct; 110(8):1641-3. PubMed ID: 17763370
[No Abstract] [Full Text] [Related]
19. Diagnosing infections--current and anticipated technologies for point-of-care diagnostics and home-based testing.
Bissonnette L; Bergeron MG
Clin Microbiol Infect; 2010 Aug; 16(8):1044-53. PubMed ID: 20670286
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the value of genomic diagnostics: implications for clinical practice and public policy.
Issa AM
Adv Health Econ Health Serv Res; 2008; 19():191-206. PubMed ID: 19548519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
